United Therapeutics
$412.80
24H
Market Cap
Volume
Supply
Price Chart
About United Therapeutics - UTHR
United Therapeutics Corporation is a biotechnology company focused on developing and commercializing innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions, particularly in the fields of pulmonary arterial hypertension and organ transplantation. Their portfolio includes several products and ongoing research in medical devices and biologic therapies.
What are United Therapeutics's core values and mission statement?
United Therapeutics Corporation's mission is to develop innovative medicines to address the unmet medical needs of patients with chronic and life-threatening conditions. Their core values focus on patient advocacy, innovation in treatment solutions, employee welfare, and sustainable practices.
Who founded United Therapeutics and when?
United Therapeutics Corporation was founded by Martine Rothblatt in 1996.
Who leads United Therapeutics?
United Therapeutics Corporation is led by Martine Rothblatt as Chairman and CEO.
Where is United Therapeutics located, and what is its base country?
United Therapeutics Corporation is headquartered in Silver Spring, Maryland, United States.
On which exchanges is United Therapeutics traded?
United Therapeutics Corporation is traded on the Nasdaq Stock Market under the ticker symbol "UTHR."
Historical data
United Therapeutics (UTHR) Price Live Data
The live price of United Therapeutics (UTHR) is $412.80, with a trading volume of 331,399 in the last 24 hours. Wrapstocks updates the UTHR price in real-time. United Therapeutics is up 2.54% in the last 24 hours. The company has a live market cap of $18,429,249,536.00 and a supply of 44,644,500 UTHR stocks.
United Therapeutics (UTHR) is traded on NASDAQ Stock Exchange, and currently, the market is open; trading will be paused in 5 hours and 49 minutes.
